Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Chinese Journal of Contemporary Pediatrics ; (12): 67-72, 2023.
Artículo en Chino | WPRIM | ID: wpr-971041

RESUMEN

OBJECTIVES@#To study the clinical features of children with autoimmune glial fibrillary acidic protein astrocytopathy (GFAP-A).@*METHODS@#A retrospective analysis was performed on the medical data of 34 children with GFAP-A who attended the Department of Neurology, Children's Hospital of Chongqing Medical University, from January 2020 to February 2022. The medical data included clinical manifestations, cerebrospinal fluid features, imaging examination results, treatment, and prognosis.@*RESULTS@#The median age of onset was 8.4 (range 1.9-14.9) years for the 34 children with GFAP-A. The main clinical manifestations included headache (50%, 17/34), fever (47%, 16/34), visual impairment (47%, 16/34), and disturbance of consciousness (44%, 15/34). Abnormal cerebrospinal fluid results were observed in 19 children (56%, 19/34), among whom 8 children had positive autoantibody. The children with overlap syndrome had significantly higher recurrence rate and rate of use of immunosuppressant than those without overlap syndrome (P<0.05). About 77% (24/31) of the children had good response to immunotherapy, and only 1 child had poor prognosis.@*CONCLUSIONS@#Children with GFAP-A often have non-specific clinical symptoms and show good response to immunotherapy. Children with overlap syndrome have a high recurrence rate, and early application of immunosuppressants may help to prevent recurrence and alleviate symptoms.


Asunto(s)
Adolescente , Niño , Preescolar , Humanos , Lactante , Astrocitos/metabolismo , Autoanticuerpos/metabolismo , Proteína Ácida Fibrilar de la Glía/metabolismo , Pronóstico , Estudios Retrospectivos , Enfermedades Autoinmunes/metabolismo
2.
Rev. chil. reumatol ; 24(4): 197-199, 2008. graf
Artículo en Español | LILACS | ID: lil-532984

RESUMEN

El factor de transcripción NFkB tiene una participación muy importante en el desarrollo y mantención de una serie de patologías humanas, principalmente aquellas con un componente inflamatorio, como la artritis reumatoide (AR). Al mismo tiempo participa en procesos tan diversos como la regulación de la respuesta inmune y el desarrollo embrionario. Una mejor comprensión de los mecanismos y funciones de NFkB permitiría el desarrollo de drogas específicas y efectivas para el tratamiento de patologías inflamatorias y autoinmunes, tratando de no interferir con las funciones normales de este sistema.


Transcription factor NFkB has an important role in development and maintenance of a lot of human pathologies, mainly those with an inflammatory component, for example rheumatoid arthritis (RA). At the same time, it participates in processes as diverse as development and immune response. A better understanding of NFkB mechanisms and functions will allow the development of more specific and effective drugs for the treatment of inflammatory and autoimmune disorders, without interfering with normal functions of this system.


Asunto(s)
Humanos , Artritis Reumatoide/metabolismo , Enfermedades Autoinmunes/metabolismo , FN-kappa B/fisiología , Inflamación/metabolismo , Artritis Reumatoide/inmunología , Enfermedades Autoinmunes/tratamiento farmacológico , FN-kappa B/antagonistas & inhibidores , FN-kappa B/inmunología , Inflamación/inmunología , Inflamación/tratamiento farmacológico
3.
Rev. méd. Chile ; 134(9): 1175-1184, sept. 2006. ilus, tab
Artículo en Español, Inglés | LILACS | ID: lil-438422

RESUMEN

BAFF (B cell activating factor belonging to the TNF family) is a cytokine implicated in the survival and maturation of peripheral B lymphocytes and T and B cell activation. BAFF binds to three different receptors: TACI, BCMA and BAFF-R, whose expression is restricted to B and T lymphocytes. BAFF and BAFF-R-deficient mice show a dramatic loss of peripheral B lymphocytes and a severely reduced immune response. In contrast, an enhanced BAFF expression leads to B cell hyperplasia and autoimmunity in mice. In vivo, administration of soluble decoy receptors for BAFF effectively decreases disease progression in various autoimmune mouse models. These evidences render BAFF as a potentially new therapeutic target. Elevated BAFF levels have been detected in the serum of patients with autoimmune diseases, such as Systemic Lupus Erythematosus, rheumatoid arthitis, Sjõgren's syndrome, lymphoid cancers and HIV infection. In addition to BAFF receptors, malignant B cells abnormally express BAFF, which attenuates apoptosis through both autocrine and paracrine pathways. The data suggest that an increase in the expression of BAFF induces an enhanced B and T cell activation and the survival of pathologically active B cells. In this article, we review and discuss the participation of BAFF and its receptors in the immune response and its involvement in immunodeficiency, autoimmunity, infections and lymphoid cancers as well as the currently investigated therapies using BAFF antagonists in the treatment of these diseases.


Asunto(s)
Animales , Humanos , Enfermedades Autoinmunes/inmunología , Autoinmunidad/fisiología , Factor Activador de Células B/inmunología , Linfocitos B/inmunología , Citocinas/inmunología , Linfoma/inmunología , Enfermedades Autoinmunes/metabolismo , Factor Activador de Células B/metabolismo , Linfocitos B/metabolismo , Citocinas/metabolismo , Modelos Animales de Enfermedad , Linfoma/metabolismo , Receptores del Factor de Necrosis Tumoral/inmunología , Receptores del Factor de Necrosis Tumoral/metabolismo
4.
Saudi Medical Journal. 2006; 27 (9): 1302-1305
en Inglés | IMEMR | ID: emr-80919

RESUMEN

Some heat shock proteins HSPs, act as molecular chaperones. These and other molecular chaperones that are not HSPs, function in a variety of protein biosynthetic event and protect proteins from the deleterious effects of stressors by stabilizing, and refolding proteins. They assist protein folding, assembly, transport and degradation. Several human diseases such as neurodegeneration, cancer, aging, retinal dystrophy, and inflammation arise from defects HSPs and protein folding. This review demonstrates the chaperones such as properties of HSPs in cellular processes and their implication in different kind of human diseases


Asunto(s)
Humanos , Chaperonas Moleculares/fisiología , Enfermedad/etiología , Encéfalo/fisiopatología , Neoplasias/metabolismo , Enfermedades Neurodegenerativas/metabolismo , Enfermedades Autoinmunes/metabolismo , Enfermedades Cardiovasculares/metabolismo
5.
Rev. invest. clín ; 57(3): 447-456, may.-jun. 2005. ilus, tab
Artículo en Español | LILACS | ID: lil-632466

RESUMEN

Prolactin (PRL) Is a 23 κDa protein hormone that is produced and secreted by the pituitary lactotrophs. Although PRL was initially regarded as an exclusive pituitary hormone, many nonpituitary tissues were later found to contain and produce this hormone. The most established extrapituitary sites that produce PRL are the decidua, the immune system, brain and endometrium. In the immune system, PRL acts as a cytokine where it plays an important role in human immune responses, including in autoimmune diseases. Here, we will discuss the regulation of PRL gene expression in human lymphocytes and review the functions of PRL made by the immune cells, including its involvement in autoimmunity.


La prolactina es una hormona que fue considerada durante mucho tiempo de origen exclusivamente hipofisario, y cuya función más importante era la promoción de la lactancia. Sin embargo, la prolactina no sólo se sintetiza en diversos sitios del organismo, sino que también participa en una amplia variedad de procesos biológicos. Dentro de los sitios de síntesis extrahipofisarios de esta hormona se encuentran diversas células del sistema inmunológico. A este nivel, la prolactina actúa afectando desde la proliferación celular hasta el estado inmune del individuo. En esta revisión presentamos algunos aspectos relativos a la prolactina de origen linfocitario tales como su síntesis, su participación en el sistema inmunológico y su relación con estados de autoinmunidad.


Asunto(s)
Animales , Femenino , Humanos , Masculino , Ratones , Sistema Inmunológico/fisiología , Prolactina/fisiología , Comunicación Autocrina , Enfermedades Autoinmunes/metabolismo , Autoinmunidad/fisiología , Diferenciación Celular/fisiología , Modelos Animales de Enfermedad , Regulación de la Expresión Génica , Leucocitos/metabolismo , Lupus Eritematoso Sistémico/metabolismo , Linfocitos/metabolismo , Ratones Endogámicos NZB , Comunicación Paracrina , Adenohipófisis/metabolismo , Adenohipófisis , Prolactina/genética , Regiones Promotoras Genéticas/genética , Receptores de Citocinas/fisiología , Receptores de Prolactina/metabolismo , Transcripción Genética
7.
Arq. bras. endocrinol. metab ; 40(2): 83-96, jun. 1996. ilus
Artículo en Portugués | LILACS | ID: lil-180130

RESUMEN

O Diabetes Mellitus Insulino-dependente (DMID) é uma doença predominantemente auto-imune, causada pela perda de tolerância dos linfócitos T a constituintes da célula beta pancreática, insulino-secretora. O auto-antígeno primário, do DMID, ainda nao está definido, tendo sido identificados vários candidatos, como: GAD ("glutamic acid decarboxylase"), insulina e outros componentes granulares. Estudos de dois modelos experimentais espontâneos, o camundongo (NOD) ("non obese diabetic") e o rato BB ("Bio breeding"), demonstraram que, a origem do DMID depende de fatores que promoveriam desequilíbrio entre subpopulaçoes T CD4+, executoras e protetoras da auto-reatividade antiilhota. Estas subpopulaçoes foram envolvidas, diretamente, na induçao e inibiçao da transferência do DMID, através de linfócitos, in vivo. Sao células T CD4+ as primariamente responsáveis pelo início da insulite, emobora a participaçao de células T CD8+ seja necessária para o desenvolvimento do DMID clínico. A patogênese da doença implica o sistema imunológico (distúrbios da manutençao da tolerância fisiológica), e a célula beta (maior suscetibilidade a agressoes). Ambos mecanismos sao modulados por vários genes, sobretudo os que codificam proteínas relacionadas com a apresentaçao antigênica (HLA), e fatores ambientais (dieta, infecçoes virais e bacterianas). A história natural do DMID compreende duas fases: 1) pré-diabetes clínico, longo período de desenvolvimento da insulite, detectado pela presença de marcadores imunológicos, como auto-anticorpos circulantes (ICA, antiGAD, IAA), e metabólicos (diminuiçao da primeira fase de insulino-secreçao), e 2) diabetes clínico, caracterizado por predomínio de insulite invasivo-destrutiva e aparecimento de síndrome hiperglicêmica.


Asunto(s)
Humanos , Animales , Masculino , Femenino , Ratones , Ratas , Enfermedades Autoinmunes/inmunología , Diabetes Mellitus Tipo 1/inmunología , Autoanticuerpos , Autoantígenos , Enfermedades Autoinmunes/genética , Enfermedades Autoinmunes/metabolismo , Diabetes Mellitus Tipo 1/genética , Diabetes Mellitus Tipo 1/metabolismo , Marcadores Genéticos , Biomarcadores , Ratones Endogámicos NOD , Síndrome
8.
Artículo en Inglés | IMSEAR | ID: sea-44019

RESUMEN

The measurement of serum TPO Ab and Tg Ab by a new direct sensitive RIA in this study are quantitative and provided a convenient system. When compared to the commonly used PH technique for TM Ab and Tg Ab, this RIA determination appears to be more sensitive than by PH, since it enabled detection of TPO Ab and/or Tg Ab in sera that were negative by PH. Thus, this RIA determination should be more widely used in a clinical laboratory.


Asunto(s)
Adulto , Anciano , Anciano de 80 o más Años , Autoanticuerpos/análisis , Enfermedades Autoinmunes/metabolismo , Estudios de Evaluación como Asunto , Femenino , Humanos , Yoduro Peroxidasa/inmunología , Masculino , Persona de Mediana Edad , Radioinmunoensayo/métodos , Tiroglobulina/inmunología , Enfermedades de la Tiroides/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA